CG
DPLO

Cutler Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Cutler Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-300
Closed -$1K – 5027
2019
Q4 		$1K Sell
300
-21,632
-99% -$102K ﹤0.01% 3873
2019
Q3 		$107K Buy
+21,932
New +$123K 0.01% 1031
2019
Q2 		– Sell
-4,884
Closed -$26K – 5090
2019
Q1 		$28K Buy
+4,884
New +$50.4K ﹤0.01% 1821
2017
Q3 		– Sell
-2,816
Closed -$47.6K – 7134
2017
Q2 		$41K Sell
2,816
-2,922
-51% -$48.7K ﹤0.01% 2708
2017
Q1 		$91K Sell
5,738
-16,746
-74% -$242K ﹤0.01% 1840
2016
Q4 		$283K Buy
22,484
+22,483
+2,248,300% +$419K 0.01% 1061
2016
Q3 		$0 Buy
+1
New +$34 ﹤0.01% 7706
2016
Q2 		– Sell
-200
Closed -$6.29K – 7610
2016
Q1 		$5K Sell
200
-325
-62% -$9.57K ﹤0.01% 4934
2015
Q4 		$17K Buy
+525
New +$16.4K ﹤0.01% 3602

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Cutler Group's DPLO Position: Q1 2020 in Review

Cutler Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 300 shares — an estimated $1K sold.

Cutler Group first reported a position in DPLO in Q4 2015 and held it in 9 quarters. The position peaked at $283K in Q4 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Cutler Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Cutler Group sold 300 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1K.
  • Cutler Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 9 quarters.
  • Cutler Group's DIPLOMAT PHARMACY, INC. position peaked at $283K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.